Clinical Study With Blinatumomab in Pediatric and Adolescent Patients With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia

NCT01471782 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
93
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Amgen Research (Munich) GmbH